Ownership history in BVF INC/IL · 6 quarters on record
This page tracks every 13F SEC filing in which BVF INC/IL reported a position in AVALO THERAPEUTICS INC (AVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,355,257 | +1 | +0.0% | 0.83% | $24.6M | $18.16 |
| 2025 Q3 | ADDED | 1,355,256 | +327,207 | +31.8% | 0.70% | $17.2M | $12.71 |
| 2025 Q2 | REDUCED | 1,028,049 | -8,630 | -0.8% | 0.18% | $5.1M | $4.99 |
| 2025 Q1 | UNCHANGED | 1,036,679 | — | 0% | 0.34% | $8.3M | $8.01 |
| 2024 Q4 | ADDED | 1,036,679 | +69,679 | +7.2% | 0.26% | $7.7M | $7.43 |
| 2024 Q3 | INITIATED | 967,000 | — | — | 0.27% | $9.1M | $9.50 |
As of 2025 Q4 — sorted by position size